|
Because no single factor influences profits more than price, it is imperative to develop an effective pricing strategy. The best price in one market may not be the optimal price in another market yet these price references are a standard for price regulation. Additionally, parallel (cross-border) trade issues are significant problems to consider and can greatly influence pricing. By starting early (i.e. well before approval) it is possible to build effective strategies that establish optimal prices by market, provide evidence to maximise reimbursement, and mitigate the effects of parallel trade.
About the Workshop Leaders:
 | Neil Palmer is responsible for leading RTI Health Solutions’ (RTI-HS) global pricing & reimbursement practice. He was co-founder of Palmer D’Angelo Consulting Inc (PDCI), a leading pharmaceutical pricing and reimbursement (P&R) consultancy established in 1996 and acquired by RTI International in December 2006. Palmer D'Angelo Consulting Inc. (www.pdci.ca) has long been recognised for its extensive knowledge and experience assisting clients with pharmaceutical price regulation, reimbursement strategies & submissions, global pricing strategies and pharmaceutical policy and economic research projects. Before founding PDCI, Mr. Palmer was a senior staffer with the Patented Medicine Prices Review Board (PMPRB) in Ottawa. Prior to the PMPRB he worked with the Health Division of Statistics Canada and the Kellogg Centre for Advanced Studies in Primary Care in Montreal. A graduate of the University of Western Ontario, he has written extensively on pharmaceutical pricing and reimbursement issues and is a frequent speaker at pharmaceutical congresses in Europe, the United States and Canada. |  | Chris Van Mol, founder of Alliance Concepts, inc., has a long and successful track record in pharmaceutical marketing and pricing. She worked in operational and strategic functions with 3 major companies: Upjohn (now part of Pfizer); Abbott and Miles/Bayer before starting her own consulting business. During 10 years she has taken on a multitude of projects with J&J on topics like global market/therapeutic/company assessments, patient based market models, portfolio forecasting, PLC planning, competitive benchmarking, insight in oncology pricing, bio-generics, combination products, post-expiry pricing, developing international price finding models, assessment of cross-border trade, evaluation of capitation pricing, launch-sequencing. Over the last 6 years she developed Pharmawiser™, a proprietary cross-functional business simulator integrating international price optimisation. Although highly conceptual, she has a pragmatic spirit and a passion for excellence. She holds a masters degree from the University of Antwerp. |
About the Organisations:
RTI-HS is a global group of more than 165 staff comprised of pricing and reimbursement experts, health outcomes scientists, health economists and other leading researchers who develop pricing and reimbursement strategies, global value dossiers, health economic models, reimbursement submissions and other related consulting and research services. RTI-HS comprehensive suite of services help optimise pricing and market access by capturing and communicating the full clinical and economic value messages of innovative new therapies www.rtihealthsolutions.com
Since 1995 Alliance Concepts inc. is dedicated to delivering top-notch, trend leading and tailored advice on crucial marketing and pricing issues to global pharma companies. The small firm agility combined with the methodology leverage of the powerful proprietary algorithms stand for fast project handling and a high return on investment. The Pharmawiser™ tool has already been implemented for price and profit optimisation with 6 very distinct products. Alliance Concepts also offers the option of software licensing www.alliance-concepts.com |
Events Home Page
